Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
- E. Walker, M. Makhay, J. D. House, A. Young
- Biology, ChemistryThe Journal of pharmacology and experimental…
- 1 November 1994
TLDR
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
- E. Walker, E. Butelman, B. Decosta, J. Woods
- Biology, MedicineThe Journal of pharmacology and experimental…
- 1 October 1993
TLDR
Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
- E. Walker, G. Zernig, J. Woods
- Biology, ChemistryThe Journal of pharmacology and experimental…
- 1 June 1995
TLDR
Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence
- E. Walker, S. Sterious
- Biology, PsychologyBritish journal of pharmacology
- 1 August 2005
TLDR
Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy
- S. Ward, S. McAllister, Rumi Kawamura, Ryuchi Murase, H. Neelakantan, E. Walker
- Biology, PsychologyBritish journal of pharmacology
- 1 February 2014
TLDR
Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory
- John J. Foley, R. Raffa, E. Walker
- Psychology, BiologyPsychopharmacology
- 8 May 2008
TLDR
Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
- S. Comer, E. Walker, E. Collins
- Biology, PsychologyPsychopharmacology
- 16 July 2005
TLDR
Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice
- Jae K. Kim, Joel S John, D. Langford, E. Walker, S. Ward, S. Rawls
- BiologyAmino Acids
- 1 March 2016
TLDR
Potency Differences ford-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2as an Antagonist of Peptide and Alkaloid μ-Agonists in an Antinociception Assay
- S. Sterious, E. Walker
- BiologyJournal of Pharmacology and Experimental…
- 1 January 2003
d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2(CTAP) is a peptide antagonist that demonstrates potent and selective affinity for μ-opioid receptors in radioligand binding assays and in vitro bioassays.…
Differential tolerance to antinociceptive effects of µ opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats
TLDR
...
1
2
3
4
5
...